BECK MACK & OLIVER LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
BECK MACK & OLIVER LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$427,812
+0.9%
4,2000.0%0.01%0.0%
Q2 2023$423,822
+9.7%
4,2000.0%0.01%0.0%
Q1 2023$386,400
-49.3%
4,200
-50.0%
0.01%0.0%
Q4 2022$762,048
+138.9%
8,400
+100.0%
0.01%
+10.0%
Q3 2022$319,000
-27.5%
4,200
-19.2%
0.01%
-23.1%
Q2 2022$440,000
-3.5%
5,2000.0%0.01%
+18.2%
Q1 2022$456,000
+0.2%
5,2000.0%0.01%0.0%
Q4 2021$455,000
+7.1%
5,2000.0%0.01%0.0%
Q3 2021$425,000
-10.3%
5,2000.0%0.01%
-15.4%
Q2 2021$474,000
-2.7%
5,200
-8.8%
0.01%
-13.3%
Q1 2021$487,000
-11.8%
5,700
-2.6%
0.02%
-16.7%
Q4 2020$552,000
+7.8%
5,850
-0.6%
0.02%
-5.3%
Q3 2020$512,000
-0.4%
5,8860.0%0.02%0.0%
Q2 2020$514,000
+27.5%
5,886
+20.5%
0.02%
+5.6%
Q1 2020$403,000
-13.0%
4,8860.0%0.02%
+20.0%
Q4 2019$463,000
+7.4%
4,886
-1.5%
0.02%0.0%
Q3 2019$431,000
-2.7%
4,959
+2.2%
0.02%
-6.2%
Q2 2019$443,000
-46.1%
4,850
-43.3%
0.02%
-44.8%
Q1 2019$822,000
+12.0%
8,5500.0%0.03%0.0%
Q4 2018$734,000
-0.4%
8,5500.0%0.03%
+26.1%
Q3 2018$737,000
+14.1%
8,5500.0%0.02%
+4.5%
Q2 2018$646,000
-6.5%
8,5500.0%0.02%
-4.3%
Q1 2018$691,000
-3.8%
8,5500.0%0.02%
-4.2%
Q4 2017$718,000
-11.2%
8,550
-9.3%
0.02%
-11.1%
Q3 2017$809,000
+2.8%
9,4260.0%0.03%
+3.8%
Q2 2017$787,000
+12.4%
9,4260.0%0.03%
+8.3%
Q1 2017$700,000
-25.7%
9,426
-27.1%
0.02%
-29.4%
Q4 2016$942,000
-27.4%
12,926
-21.3%
0.03%
-27.7%
Q3 2016$1,297,000
-4.3%
16,4260.0%0.05%
-2.1%
Q2 2016$1,355,000
+13.9%
16,4260.0%0.05%
+14.3%
Q1 2016$1,190,000
-15.8%
16,4260.0%0.04%
-12.5%
Q4 2015$1,413,000
-41.9%
16,426
-37.9%
0.05%
-35.1%
Q3 2015$2,431,000
-10.5%
26,449
-4.2%
0.07%
+4.2%
Q2 2015$2,715,000
-0.9%
27,599
-0.7%
0.07%
+2.9%
Q1 2015$2,741,000
+4.5%
27,799
-1.8%
0.07%
+7.8%
Q4 2014$2,623,000
-1.5%
28,2990.0%0.06%
+1.6%
Q3 2014$2,664,000
+4.0%
28,2990.0%0.06%
+8.6%
Q2 2014$2,562,000
+5.9%
28,299
-0.5%
0.06%
+1.8%
Q1 2014$2,419,000
+4.9%
28,449
-0.8%
0.06%
+1.8%
Q4 2013$2,305,000
+4.8%
28,6790.0%0.06%
-3.4%
Q3 2013$2,200,000
+7.7%
28,679
-0.7%
0.06%
+3.6%
Q2 2013$2,042,00028,8790.06%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders